USPTO serial 79227419
SPLEEN TO SCREEN
Reviewed by CopyMark Law Group
Reg. 5830546Status 708Registered
- Filing date
- Status date
- Registration date
- Aug 13, 2019
- Examiner
- NELMAN, JESSE M
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SPLEEN TO SCREEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Max Vern
Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Biochemical products used in the medical and pharmaceutical industry and in science, in particular antibodies in the nature of protein mixtures for rapidly screening panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical and veterinary preparations prepared with antibodies in the nature of protein mixtures used in the medical and pharmaceutical industry and in science for the treatment of cancer and other therapeutic indications, namely, for the generation of mono and multispecific biologics being biological preparations in the fields of immuno-oncology and auto-immune diseases] | SECTION 71 - CANCELLED | — |
| 042 | Services of biochemists, namely, scientific and medical laboratory services in the nature of efficient screening of antibodies in the nature of protein mixtures for the generation of mono and multispecific biologics; [ services of bacteriologic and biochemical laboratories, namely, research in the field of biochemistry; professional advice relating to biochemistry; ] conducting scientific and industrial research using laboratory techniques, [ namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and preparing related professional reports; professional advice relating to scientific and industrial research using laboratory techniques, namely, the extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; ] reviewing and analyzing anti-bodies [ in the nature of protein mixtures used in the medical and pharmaceutical industry and in science and the preparation of related professional reports for scientists, engineers, analysts and laboratory assistants and technicians for industry and government services; scientific and industrial research, in particular in the field of the aforementioned anti-bodies, namely, anti-bodies in the nature of protein mixtures; research and development of new products for others, in particular anti-bodies in the nature of protein mixtures; chemical and laboratory research services, namely, performing extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports; consultancy relating to chemical and laboratory research services, namely, the performance of extraction, fragmentation, cloning, transformation, isolation, concatenation, complementing, selection, identification and compilation of cells and genetic materials in the nature of DNA and the preparation of related professional reports ] | ACTIVE | — |
| 044 | [ Medical services; veterinary services; genetic testing of research animals, in particular of transgenic mice for research purposes ] | SECTION 71 - CANCELLED | — |
| 045 | [ Legal services; legal services relating to exploitation of intellectual property rights; licensing of intellectual property rights; legal advisory services in the aforementioned fields, namely, exploitation of intellection property rights and licensing of intellectual property rights, concerning rapid screening of panels of target-specific antibodies for the downstream production of, and for the manufacture of, mono and multispecific biologics in the fields of immuno-oncology and auto-immune diseases ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Merus N.V.
- Other trademarks owned by Merus B.V.
- Other trademarks owned by Merus N.V.
- Other trademarks owned by Merus N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named SPLEEN TO SCREEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 11, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jun 11, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jun 1, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 28, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 28, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 28, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| May 28, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 28, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 28, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 7, 2026 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Mar 19, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 13, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Feb 9, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 9, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 9, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 13, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 30, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 30, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 30, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 30, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 30, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 30, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 13, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 26, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 26, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 13, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 9, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 24, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 24, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 28, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 28, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 24, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 8, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 8, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 8, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 19, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 19, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 19, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 19, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 5, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 8, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 6, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 2, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 1, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |